Development progress and application of monoclonal antibody drugs against respiratory virus / 中国生物制品学杂志
Chinese Journal of Biologicals
; (12): 89-97, 2023.
Article
en Zh
| WPRIM
| ID: wpr-965585
Biblioteca responsable:
WPRO
ABSTRACT
@#Abstract:In recent years,the outbreak and prevalence of respiratory infectious diseases in the world seriously endanger human health,among which the respiratory infectious diseases caused by viral infection account for a large proportion. The use of vaccines and common antiviral drugs is an effective way to fight viral infection,but there are also problems such as lag and drug resistance. Monoclonal antibodies against respiratory viral infections provide a new strategy for clinical treatment. This paper reviews the development of monoclonal antibody against respiratory virus and its application in respiratory viral infectious diseases. Keywords:Respiratory viral infectious diseases;Respiratory syncytial virus(RSV);Influenza virus(IFV);Coronavirus (CoV);Monoclonal antibody
Buscar en Google
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Biologicals
Año:
2023
Tipo del documento:
Article